
|Podcasts|March 2, 2022
S4E3: Myfembree for moderate-to-severe endometriosis pain: Potential for adolescents
Author(s)Lindsey Carr, Editor, Jessica Y. Shim, MD
In this episode of Pap Talk, Contemporary OB/GYN® Associate Editor Lindsey Carr sat down with Jessica Shim, MD, an attending at in the Division of Gynecology, Department of Surgery, Boston Children’s Hospital; Harvard Medical School Boston, Massachusetts, to discuss Myfembree (relugolix, estradiol, and norethindrone acetate tablets; Myovant Sciences, Pfizer) and its possible approval in May 2022.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Minipad-based HPV testing shows promise for cervical cancer screening
2
Study data highlight trade-offs of testing for pregnancy too soon
3
Kevin Ault, MD, on vaccines & autism, local government, HPV vaccine advocacy
4
Barbara Levy, MD, on importance of public comments on new cervical cancer screening guidance
5








